Search Results - Jacob M. Rowe
- Showing 1 - 1 results of 1
-
1
Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction by Meira Yisraeli Salman, Alexander R. Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Yannis K. Valtis, Leora Boussi, Theresa Spivey, Wenbin Xiao, Christopher Famulare, Jenna Ciervo, Jacob M. Rowe, Martin S. Tallman, Eytan M. Stein
Published 2025-07-01
Article